C. Canavan

13 papers receiving 1.0k citations

Hit Papers

Review article: the economic impact of the irritable bowel syndrome 2014 · 351 citations
3512014202620182022100200300

Peers

C. Canavan
Comparison fields: 5 of 83
  • Gastroenterology 390
  • Genetics 447
  • Epidemiology 397
  • Complementary and Manual Therapy 24
  • Pharmacy 41
Replace Karen Lasch with:
Karen Lasch United States
Albert Villòria Spain
Bobby Lo Denmark
R. Gillberg Sweden
Magnus Ström Sweden
Tibor Hlavatý Slovakia
P. Usai Italy
Jan E. Irvine Canada
P. Molteni Italy
Arun Swaminath United States
C. Canavan relative to Karen Lasch United States Karen Lasch's profile →
Citations per field
00.5×1.6×
Karen Lasch · 1×
Citations per year

Countries citing papers authored by C. Canavan

Since Specialization
Citations

This map shows the geographic impact of C. Canavan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Canavan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Canavan more than expected).

Fields of papers citing papers by C. Canavan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Canavan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Canavan. The network helps show where C. Canavan may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Canavan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Canavan Line = papers co-authored together C. Canavan links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1 2006426
2
Review article: the economic impact of the irritable bowel syndrome
Hit paper breakdown →
2014351
3 2007101
4 200665
5 201136
6 200626
7 201323
8 19949
9 19888
10 19955
11 20164
12 20192
13 20061
14 20131
15 20240

About C. Canavan

C. Canavan is a scholar working on Gastroenterology, Internal Medicine, Epidemiology, Hepatology and Genetics, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Microscopic Colitis (5 papers), Inflammatory Bowel Disease (5 papers), Eosinophilic Esophagitis (3 papers), Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Gastric Cancer Management and Outcomes (2 papers), Bartonella species infections research (1 paper) and Acne and Rosacea Treatments and Effects (1 paper). The work is most often cited by research in Gastroenterology (390 citations), Genetics (447 citations), Epidemiology (397 citations), Complementary and Manual Therapy (24 citations) and Pharmacy (41 citations). C. Canavan has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Keith R. Abrams, J F Mayberry, Joe West, Tim Card, Douglas A. Drossman, Kay‐Tee Khaw, Richard F. Logan, Kathleen E. Corey, Lingyu Meng and Chin Hur. Their work appears in journals such as Alimentary Pharmacology & Therapeutics, Heart, Digestive Diseases and Sciences, Gut and Canadian Journal of Physiology and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026